October 13, 2025

Abbott Laboratories (ABT) Stock Analysis: A Healthcare Giant with a 7.96% Upside

Abbott Laboratories (NYSE: ABT), a stalwart in the healthcare sector, continues to capture investor attention with its impressive market cap of $230.73 billion. As a leading player in the medical..

The Cigna Group (CI) Stock Analysis: Exploring a 21.49% Upside Potential for Investors

The Cigna Group (NYSE: CI), a stalwart in the healthcare sector with a robust market cap of $80.27 billion, presents a compelling opportunity for investors seeking exposure to the healthcare..

IQVIA Holdings, Inc. (IQV) Stock Analysis: Evaluating a Potential 11% Upside in the Healthcare Sector

IQVIA Holdings, Inc. (IQV) is making waves in the healthcare sector, standing out with a robust market capitalization of $33.69 billion. As a prominent name in the Diagnostics & Research..

Sanofi (SNY) Stock Analysis: Potential Upside and Strong Dividend Yield Attract Investor Interest

Sanofi (SNY), a leading player in the global healthcare sector, presents a compelling case for investors looking to capitalize on both stable dividend income and significant growth potential. With a..

HCA Healthcare, Inc. (HCA) Stock Analysis: Strong Revenue Growth Amid Sector Challenges

HCA Healthcare, Inc. (NYSE: HCA), a titan in the healthcare sector, operates a vast network of medical care facilities across the United States. With a market capitalization of $97.14 billion,..

Merck & Company, Inc. (MRK) Stock Analysis: Navigating a 17.92% Potential Upside in the Healthcare Sector

Merck & Company, Inc. (NYSE: MRK) stands as a towering presence in the healthcare sector, particularly within the drug manufacturing industry. With a substantial market capitalization of $214.78 billion, this..

Johnson & Johnson (JNJ) Stock Analysis: Evaluating the Resilience and Growth Potential Amidst Market Dynamics

Johnson & Johnson (NYSE: JNJ), a stalwart in the healthcare sector, continues to capture the attention of investors with its robust market position and diverse product portfolio. As one of..

Eli Lilly and Company (LLY) Stock Analysis: Exploring Growth and Valuation Potential in Healthcare

Eli Lilly and Company (NYSE: LLY) stands as a titan in the healthcare sector, renowned for its innovative contributions to pharmaceuticals. With a market capitalization of $747.19 billion, Eli Lilly..

Intuitive Surgical, Inc. (ISRG) Stock Analysis: Navigating a 34.30% Potential Upside in Healthcare Innovation

Intuitive Surgical, Inc. (NASDAQ: ISRG), a front-runner in the healthcare sector, continues to capture investor interest with its cutting-edge medical instruments and supplies. With a market capitalization of $154 billion,..

European indices shift gear as external tension signals flicker

A calmer tone from Washington gave European equities room to rebound, offering investors a window into selective opportunities across key sectors...

Legal & General appoints Scott Wheway as Chair to succeed Sir John Kingman

Legal & General Group Plc has appointed Scott Wheway to succeed Sir John Kingman as Chair. Scott will join the Board on 2 January 2026 as Chair Designate and assume..

Norcros completes acquisition of Norwegian wall panel specialist Fibo

Norcros plc has received unconditional clearance from the UK Competition and Markets Authority for its £46 million acquisition of Fibo Holding AS, a leading supplier of waterproof decorative wall panels...

Aptamer Group secures repeat contract for Optimer® binder development

Aptamer Group has signed a new agreement with an existing partner to develop Optimer® binders targeting two proteins for biomarker research...

JPMorgan European Discovery Trust Factsheet August 2025: European sentiment strengthens

JEDT performance over the year remains highly encouraging. The share price has climbed 28.3% and NAV 22.8% over twelve months, both comfortably ahead of the benchmark’s 14.1% rise...

IP Group sees revenue potential from Metsera obesity drug deal

IP Group plc has outlined potential future revenue opportunities from obesity drug candidates developed by Metsera, following Pfizer’s agreement to acquire Metsera for up to $7.3 billion...

Ferro-Alloy Resources reports strong feasibility study for Balasausqandiq project

Ferro-Alloy Resources has reported positive results from its feasibility study on Phase 1 of the Balasausqandiq vanadium project in Southern Kazakhstan, showing a post-tax NPV of US$748 million and an..

Avation secures eight-year lease for ATR 72-600 with European ACMI provider

Avation has signed an eight-year lease agreement with a European ACMI provider for an eight-year-old ATR 72-600 aircraft, set to transition in February 2026...

AstraZeneca Plc reaches agreement with Trump administration to cut US drug prices

AstraZeneca has signed a landmark agreement with President Donald J. Trump’s administration to reduce the cost of prescription medicines for American patients...

TESCO PLC ORD 6 1/3P (TSCO.L)

⚠️ No article content returned.

..

SEGRO PLC ORD 10P (SGRO.L) Stock Analysis: Exploring a 20% Potential Upside in the Industrial REIT Sector

SEGRO PLC ORD 10P (SGRO.L) stands as a formidable player in the real estate investment trust (REIT) sector, focusing on industrial properties. With a market capitalization of $8.82 billion, this..

Search

Funds

October 13, 2025

European indices shift gear as external tension signals flicker

A calmer tone from Washington gave European equities room to rebound, offering investors a window into selective opportunities across key sectors...

Legal & General appoints Scott Wheway as Chair to succeed Sir John Kingman

Legal & General Group Plc has appointed Scott Wheway to succeed Sir John Kingman as Chair. Scott will join the Board on 2 January 2026 as Chair Designate and assume the role following the AGM on 21 May 2026...

Norcros completes acquisition of Norwegian wall panel specialist Fibo

Norcros plc has received unconditional clearance from the UK Competition and Markets Authority for its £46 million acquisition of Fibo Holding AS, a leading supplier of waterproof decorative wall panels...

Aptamer Group secures repeat contract for Optimer® binder development

Aptamer Group has signed a new agreement with an existing partner to develop Optimer® binders targeting two proteins for biomarker research...

JPMorgan European Discovery Trust Factsheet August 2025: European sentiment strengthens

JEDT performance over the year remains highly encouraging. The share price has climbed 28.3% and NAV 22.8% over twelve months, both comfortably ahead of the benchmark’s 14.1% rise...

IP Group sees revenue potential from Metsera obesity drug deal

IP Group plc has outlined potential future revenue opportunities from obesity drug candidates developed by Metsera, following Pfizer’s agreement to acquire Metsera for up to $7.3 billion...

Ferro-Alloy Resources reports strong feasibility study for Balasausqandiq project

Ferro-Alloy Resources has reported positive results from its feasibility study on Phase 1 of the Balasausqandiq vanadium project in Southern Kazakhstan, showing a post-tax NPV of US$748 million and an IRR of 22%...

Avation secures eight-year lease for ATR 72-600 with European ACMI provider

Avation has signed an eight-year lease agreement with a European ACMI provider for an eight-year-old ATR 72-600 aircraft, set to transition in February 2026...

AstraZeneca Plc reaches agreement with Trump administration to cut US drug prices

AstraZeneca has signed a landmark agreement with President Donald J. Trump’s administration to reduce the cost of prescription medicines for American patients...
Search

Funds

October 13, 2025

FTSE 100

Funds